JWG-071

DL-071-IT

TAK-071

Luseogliflozin

Butanedioic acid, sulfo-, 4-[2-[(2-hydroxyethyl)amino]ethyl] ester, N-coco acyl derivs., disodium salts

Chromate(3-), [4-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulfonato(3-)][3-hydroxy-4-[(2-hydroxy-1-naphthalenyl)azo]-7-nitro-1-naphthalenesulfonato(3-)]-, trisodium

hydrogen bis[2-chloro-5-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-N-methylbenzenesulphonamidato(2-)]cobaltate(1-) , compound with cyclohexylamine (1:1)

4-(2-Chloro-5-methylphenyl)butan-2-amine

1-Benzoxepin-5(2H)-one, 3,4-dihydro-4-hydroxy-

(1R)-2-Methoxy-1-(pyrimidin-2-YL)ethan-1-amine

tert-butyl N-[3-(bromomethyl)oxolan-3-yl]carbamate

6-Methoxy-2-(2,2,2-trifluoroacetyl)isoindoline-5-sulfonyl chloride

6-Chloro-9-ethyl-8-(1-ethyl-5-methyl-1H-pyrazol-4-yl)-9H-purine

2-(2,6-dioxopiperidin-3-yl)-5-[4-(pyrrolidin-3-yl)piperazin-1-yl]-2,3-dihydro-1H-isoindole-1,3-dione

4-(2-Chloro-6-methylphenyl)butan-2-amine

(S)-1-(1-benzylpiperidin-4-yl)pyrrolidin-3-ol

4-(Bromomethyl)-4-fluorocyclohexan-1-one